Apollo Hospitals is set to release its earnings report for the quarter ended September 2023 (Q2FY24) on Thursday, November 9, 2023.

According to a CNBC-TV18 poll, the second quarter revenue growth is expected to reach 12% at ₹4,770 crore, compared to the ₹ 4,251.07 crore reported in the same quarter last year.

However, it is anticipated that the margin will decrease to 12.6% from 13.3% in Q2FY23.

Profit after tax is projected to experience a surge of 38%, reaching ₹293 crore, in contrast to the ₹213 crore recorded in the same quarter the previous year.

The second quarter is expected to be relatively soft due to factors such as slightly delayed rains, resulting in an estimated 7-9% growth in hospital segment revenue. Nevertheless, market participants anticipate an increase in bed occupancy on a quarter-on-quarter basis.

Apollo HealthCo, comprising Apollo 24/7 and the backend pharmacy business, is anticipated to report a year-on-year growth of 15-20%.

Meanwhile, Apollo Health & Lifestyle, the company's clinic business, is likely to see growth in the range of 3-4%.

Management commentary on fundraising plans and future margins will play a crucial role in influencing the stock's performance.

On Wednesday, the stock closed at ₹5,116.05 per share, marking a 0.40% decline from the previous day's closing price. Over the past six months, the stock has registered a gain of 11.39%.